SCM
Silverarc Capital Management’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-20,000
| Closed | -$843K | – | 81 |
|
2023
Q4 | $843K | Buy |
+20,000
| New | +$843K | 0.25% | 58 |
|
2023
Q1 | – | Sell |
-519,614
| Closed | -$9.22M | – | 84 |
|
2022
Q4 | $9.22M | Buy |
519,614
+219,614
| +73% | +$3.9M | 2.64% | 7 |
|
2022
Q3 | $1.67M | Buy |
+300,000
| New | +$1.67M | 0.57% | 42 |
|
2021
Q2 | – | Sell |
-50,400
| Closed | -$808K | – | 101 |
|
2021
Q1 | $808K | Sell |
50,400
-49,600
| -50% | -$795K | 0.44% | 56 |
|
2020
Q4 | $4.62M | Buy |
+100,000
| New | +$4.62M | 2.68% | 9 |
|